{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:55:58Z","timestamp":1781661358572,"version":"3.54.5"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019460","name":"Weill Cornell Medicine - Qatar","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019460","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Translational Autoimmunity"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jtauto.2026.100373","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T23:09:43Z","timestamp":1776985783000},"page":"100373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Anti-Annexin A5 antibodies and Annexin A5 resistance in antiphospholipid syndrome: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1356-0835","authenticated-orcid":false,"given":"Laith","family":"Alamlih","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0715-2993","authenticated-orcid":false,"given":"Karima","family":"Becetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7942-4831","authenticated-orcid":false,"given":"Samar","family":"Al Emadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman","family":"satti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2775-6658","authenticated-orcid":false,"given":"Zahir M.","family":"Tag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8756-6968","authenticated-orcid":false,"given":"Hiam","family":"Chemaitelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Abu-Tineh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Abufaied","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa'ad","family":"Laws","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8927-6024","authenticated-orcid":false,"given":"Munther","family":"Khamashta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jtauto.2026.100373_bib1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J. Thromb. Haemostasis"},{"issue":"8","key":"10.1016\/j.jtauto.2026.100373_bib2","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/rheumatology\/ket126","article-title":"Seronegative antiphospholipid syndrome","volume":"52","author":"Nayfe","year":"2013","journal-title":"Rheumatology"},{"issue":"12","key":"10.1016\/j.jtauto.2026.100373_bib3","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1136\/ard.2003.006163","article-title":"Seronegative antiphospholipid syndrome","volume":"62","author":"Hughes","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2026.100373_bib4","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.placenta.2024.06.019","article-title":"Criteria and non-criteria antiphospholipid autoantibodies screening in patients with late pregnancy morbidity: a cross-sectional study","volume":"154","author":"Gros","year":"2024","journal-title":"Placenta"},{"issue":"15","key":"10.1016\/j.jtauto.2026.100373_bib5","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.3390\/diagnostics13152507","article-title":"Anti-phosphatidylserine, anti-prothrombin, and anti-annexin V autoantibodies in antiphospholipid syndrome: a real-life study","volume":"13","author":"Roselli","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.jtauto.2026.100373_bib6","article-title":"Non-criteria antiphospholipid antibodies in antiphospholipid syndrome: diagnostic value added","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.jtauto.2026.100373_bib7","first-page":"552","article-title":"The diagnostic value of new additional antiphospholipid antibodies in antiphospholipid syndrome","volume":"51","author":"Khogeer","year":"2021","journal-title":"Ann. Clin. Lab. Sci."},{"issue":"5","key":"10.1016\/j.jtauto.2026.100373_bib8","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00418-018-1709-2","article-title":"Reimagining the antiphospholipid syndrome, an enigmatic thrombophilic disorder, through the looking glass of microscopic imaging","volume":"150","author":"Rand","year":"2018","journal-title":"Histochem. Cell Biol."},{"issue":"6","key":"10.1016\/j.jtauto.2026.100373_bib9","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0143-4004(05)80407-2","article-title":"The expression of the placental anticoagulant protein, annexin V, by villous trophoblasts: immunolocalization and in vitro regulation","volume":"15","author":"Krikun","year":"1994","journal-title":"Placenta"},{"issue":"3","key":"10.1016\/j.jtauto.2026.100373_bib10","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1006\/jsbi.2000.4286","article-title":"Surface topography of the p3 and p6 annexin V crystal forms determined by atomic force microscopy","volume":"131","author":"Reviakine","year":"2000","journal-title":"J. Struct. Biol."},{"issue":"5","key":"10.1016\/j.jtauto.2026.100373_bib11","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1182\/blood-2008-03-144204","article-title":"Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers","volume":"112","author":"Rand","year":"2008","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.jtauto.2026.100373_bib12","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1177\/0961203308095029","article-title":"Resistance to annexin A5 anticoagulant activity: a thrombogenic mechanism for the antiphospholipid syndrome","volume":"17","author":"Rand","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.jtauto.2026.100373_bib13","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","year":"2008"},{"key":"10.1016\/j.jtauto.2026.100373_bib14","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"Br. Med. J."},{"issue":"4","key":"10.1016\/j.jtauto.2026.100373_bib15","first-page":"138","article-title":"The inverse of the Freeman\u2013Tukey double arcsine transformation","volume":"32","author":"Miller","year":"1978","journal-title":"Am. Stat."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100373_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/bmjos-2020-100074","article-title":"Comparison of commonly used methods in random effects meta-analysis: application to preclinical data in drug discovery research","volume":"5","author":"Tanriver-Ayder","year":"2021","journal-title":"BMJ Open Sci."},{"issue":"11","key":"10.1016\/j.jtauto.2026.100373_bib17","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"key":"10.1016\/j.jtauto.2026.100373_bib18","series-title":"Systematic Reviews in Health Research: Meta-Analysis in Context","article-title":"Meta-analysis in R","author":"Schwarzer","year":"2022"},{"issue":"2","key":"10.1016\/j.jtauto.2026.100373_bib19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10067-016-3510-8","article-title":"Evaluation of the clinical relevance of anti-annexin-A5 antibodies in Chinese patients with antiphospholipid syndrome","volume":"36","author":"Zhang","year":"2017","journal-title":"Clin. Rheumatol."},{"issue":"7","key":"10.1016\/j.jtauto.2026.100373_bib20","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1111\/jth.13699","article-title":"Reduction of annexin A5 anticoagulant ratio identifies antiphospholipid antibody-positive patients with adverse clinical outcomes","volume":"15","author":"Wolgast","year":"2017","journal-title":"J. Thromb. Haemostasis"},{"issue":"3","key":"10.1016\/j.jtauto.2026.100373_bib21","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3324\/haematol.2019.221945","article-title":"Seronegative antiphospholipid syndrome: refining the value of \"non-criteria\" antibodies for diagnosis and clinical management","volume":"105","author":"Pignatelli","year":"2020","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.jtauto.2026.100373_bib22","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0002-9440(10)63479-7","article-title":"Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay","volume":"163","author":"Rand","year":"2003","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.jtauto.2026.100373_bib23","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13822","article-title":"Preconception anti-annexin A5 antibodies are associated with subsequent live birth in women with recurrent miscarriage: a retrospective study from China","volume":"91","author":"Mu","year":"2024","journal-title":"Am. J. Reprod. Immunol."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100373_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-49768-w","article-title":"\"In House\" assays for the quantification of Annexin V and its autoantibodies in patients with recurrent pregnancy loss and in vitro fertilisation failures","volume":"13","author":"Murad","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100373_bib25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2141.2007.06751.x","article-title":"Antiphospholipid antibody syndrome: the flow cytometric annexin A5 competition assay as a diagnostic tool","volume":"139","author":"Tomer","year":"2007","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.jtauto.2026.100373_bib26","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1182\/blood.V92.5.1652","article-title":"Antiphospholipid antibodies accelerate plasma coagulation by inhibiting Annexin-V binding to phospholipids: a \u201cLupus Procoagulant\u201d phenomenon","volume":"92","author":"Rand","year":"1998","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jtauto.2026.100373_bib27","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1136\/ard.2005.045237","article-title":"Annexin A5 polymorphism (-1C- - >T) and the presence of anti-annexin A5 antibodies in the antiphospholipid syndrome","volume":"65","author":"de Laat","year":"2006","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"10.1016\/j.jtauto.2026.100373_bib28","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1093\/rheumatology\/kev226","article-title":"Examining the prevalence of non-criteria anti-phospholipid antibodies in patients with anti-phospholipid syndrome: a systematic review","volume":"54","author":"Rodr\u00edguez-Garc\u00eda","year":"2015","journal-title":"Rheumatology"},{"issue":"7","key":"10.1016\/j.jtauto.2026.100373_bib29","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1177\/096120330000900707","article-title":"Determination of autoantibodies to annexin XI in systemic autoimmune diseases","volume":"9","author":"Jorgensen","year":"2000","journal-title":"Lupus"},{"issue":"10","key":"10.1016\/j.jtauto.2026.100373_bib30","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/ard-2023-224609","article-title":"2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"82","author":"Barbhaiya","year":"2023","journal-title":"Ann. Rheum. Dis."}],"container-title":["Journal of Translational Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909026000262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909026000262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:26:03Z","timestamp":1781659563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589909026000262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":30,"alternative-id":["S2589909026000262"],"URL":"https:\/\/doi.org\/10.1016\/j.jtauto.2026.100373","relation":{},"ISSN":["2589-9090"],"issn-type":[{"value":"2589-9090","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-Annexin A5 antibodies and Annexin A5 resistance in antiphospholipid syndrome: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Translational Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtauto.2026.100373","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100373"}}